| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Ossification, Heterotopic | 24 | 2020 | 239 | 6.600 |
Why?
|
| Lymphatic Vessels | 4 | 2023 | 353 | 1.870 |
Why?
|
| Lymphedema | 4 | 2023 | 534 | 1.680 |
Why?
|
| Burns | 17 | 2020 | 1815 | 1.610 |
Why?
|
| Wounds and Injuries | 12 | 2019 | 2400 | 1.390 |
Why?
|
| Mammaplasty | 5 | 2019 | 1204 | 1.220 |
Why?
|
| Mesenchymal Stem Cells | 13 | 2020 | 1632 | 1.220 |
Why?
|
| Wound Healing | 13 | 2020 | 2785 | 1.120 |
Why?
|
| Bone Morphogenetic Protein Receptors | 2 | 2017 | 47 | 1.110 |
Why?
|
| Receptor, Platelet-Derived Growth Factor alpha | 3 | 2023 | 379 | 1.040 |
Why?
|
| Osteogenesis | 12 | 2018 | 1299 | 1.040 |
Why?
|
| Osteoblasts | 5 | 2019 | 1166 | 1.020 |
Why?
|
| Mastectomy | 6 | 2022 | 1793 | 1.010 |
Why?
|
| Breast Implantation | 2 | 2017 | 218 | 0.890 |
Why?
|
| Breast Implants | 2 | 2017 | 387 | 0.830 |
Why?
|
| X-Ray Microtomography | 7 | 2016 | 428 | 0.830 |
Why?
|
| Breast Neoplasms | 10 | 2023 | 20822 | 0.820 |
Why?
|
| Neovascularization, Physiologic | 3 | 2019 | 1351 | 0.810 |
Why?
|
| Activin Receptors, Type I | 6 | 2017 | 142 | 0.800 |
Why?
|
| Muscles | 2 | 2016 | 1614 | 0.790 |
Why?
|
| Chondrogenesis | 4 | 2016 | 247 | 0.740 |
Why?
|
| Lymph Node Excision | 5 | 2023 | 1261 | 0.630 |
Why?
|
| Cartilage | 3 | 2016 | 818 | 0.630 |
Why?
|
| Bone Morphogenetic Proteins | 4 | 2016 | 838 | 0.600 |
Why?
|
| Spectrum Analysis, Raman | 2 | 2016 | 247 | 0.600 |
Why?
|
| Burns, Electric | 1 | 2016 | 42 | 0.560 |
Why?
|
| Cicatrix, Hypertrophic | 1 | 2017 | 79 | 0.560 |
Why?
|
| Myositis Ossificans | 1 | 2016 | 79 | 0.540 |
Why?
|
| Bone and Bones | 3 | 2016 | 2575 | 0.540 |
Why?
|
| Skin Transplantation | 3 | 2017 | 1074 | 0.530 |
Why?
|
| Arm Injuries | 1 | 2017 | 160 | 0.530 |
Why?
|
| Tendons | 2 | 2016 | 548 | 0.520 |
Why?
|
| Achilles Tendon | 6 | 2016 | 157 | 0.520 |
Why?
|
| Tenotomy | 6 | 2016 | 49 | 0.510 |
Why?
|
| Endothelial Cells | 2 | 2019 | 3479 | 0.500 |
Why?
|
| Gene Targeting | 2 | 2017 | 880 | 0.490 |
Why?
|
| Stress, Mechanical | 1 | 2019 | 1686 | 0.480 |
Why?
|
| Mastectomy, Subcutaneous | 1 | 2014 | 46 | 0.460 |
Why?
|
| Disease Models, Animal | 16 | 2020 | 18029 | 0.450 |
Why?
|
| Median Neuropathy | 1 | 2012 | 8 | 0.450 |
Why?
|
| Abdomen | 2 | 2016 | 1118 | 0.450 |
Why?
|
| Cicatrix | 1 | 2019 | 764 | 0.440 |
Why?
|
| Stem Cell Transplantation | 3 | 2016 | 1620 | 0.430 |
Why?
|
| Nipples | 1 | 2014 | 219 | 0.430 |
Why?
|
| Free Tissue Flaps | 1 | 2016 | 328 | 0.420 |
Why?
|
| Hypoxia-Inducible Factor 1, alpha Subunit | 1 | 2015 | 627 | 0.410 |
Why?
|
| Device Removal | 1 | 2017 | 656 | 0.410 |
Why?
|
| Mice, Inbred C57BL | 19 | 2023 | 21827 | 0.410 |
Why?
|
| Incidental Findings | 1 | 2016 | 689 | 0.400 |
Why?
|
| Epithelial-Mesenchymal Transition | 1 | 2016 | 713 | 0.400 |
Why?
|
| SOX9 Transcription Factor | 3 | 2016 | 146 | 0.390 |
Why?
|
| Hamartoma | 1 | 2012 | 238 | 0.380 |
Why?
|
| Basic Helix-Loop-Helix Transcription Factors | 1 | 2016 | 1114 | 0.380 |
Why?
|
| Blood Vessels | 1 | 2016 | 1125 | 0.370 |
Why?
|
| Integrases | 4 | 2019 | 533 | 0.370 |
Why?
|
| Neutrophils | 2 | 2019 | 3719 | 0.350 |
Why?
|
| Mice | 27 | 2023 | 81183 | 0.350 |
Why?
|
| Axilla | 2 | 2023 | 595 | 0.340 |
Why?
|
| Animals | 36 | 2023 | 168757 | 0.340 |
Why?
|
| Signal Transduction | 10 | 2019 | 23403 | 0.330 |
Why?
|
| Lymphangiogenesis | 2 | 2022 | 172 | 0.330 |
Why?
|
| Gastric Bypass | 1 | 2017 | 812 | 0.320 |
Why?
|
| Cell Lineage | 1 | 2016 | 2504 | 0.300 |
Why?
|
| Preoperative Care | 1 | 2016 | 2250 | 0.300 |
Why?
|
| Leptin | 1 | 2015 | 1599 | 0.300 |
Why?
|
| TOR Serine-Threonine Kinases | 1 | 2016 | 2109 | 0.300 |
Why?
|
| Hernia, Ventral | 3 | 2014 | 176 | 0.300 |
Why?
|
| Cell Movement | 1 | 2019 | 5217 | 0.300 |
Why?
|
| Survival Analysis | 2 | 2017 | 10252 | 0.300 |
Why?
|
| Fibrosis | 4 | 2023 | 2029 | 0.290 |
Why?
|
| Mice, Transgenic | 7 | 2020 | 9734 | 0.290 |
Why?
|
| Carcinoma, Ductal, Breast | 1 | 2014 | 1101 | 0.280 |
Why?
|
| Obesity, Morbid | 1 | 2017 | 1213 | 0.280 |
Why?
|
| Muscle, Skeletal | 6 | 2023 | 4931 | 0.270 |
Why?
|
| Stem Cells | 2 | 2016 | 3567 | 0.270 |
Why?
|
| Models, Genetic | 1 | 2016 | 3494 | 0.270 |
Why?
|
| Weight Loss | 1 | 2017 | 2622 | 0.270 |
Why?
|
| Muscular Diseases | 2 | 2023 | 556 | 0.270 |
Why?
|
| Vascular Endothelial Growth Factor A | 3 | 2023 | 3508 | 0.260 |
Why?
|
| SEER Program | 3 | 2015 | 1508 | 0.250 |
Why?
|
| Patient Selection | 1 | 2017 | 4215 | 0.250 |
Why?
|
| Patient Education as Topic | 1 | 2015 | 2278 | 0.250 |
Why?
|
| Patient Compliance | 1 | 2015 | 2684 | 0.240 |
Why?
|
| Cell Differentiation | 8 | 2020 | 11483 | 0.240 |
Why?
|
| Bone Regeneration | 2 | 2019 | 427 | 0.230 |
Why?
|
| Hindlimb | 2 | 2016 | 504 | 0.230 |
Why?
|
| Socioeconomic Factors | 1 | 2017 | 7785 | 0.230 |
Why?
|
| Health Care Costs | 1 | 2016 | 3209 | 0.220 |
Why?
|
| Regeneration | 4 | 2023 | 1485 | 0.220 |
Why?
|
| Graft Rejection | 2 | 2015 | 4397 | 0.210 |
Why?
|
| Peroxisome Proliferator-Activated Receptors | 1 | 2022 | 65 | 0.210 |
Why?
|
| Microsurgery | 3 | 2020 | 796 | 0.210 |
Why?
|
| Sternum | 2 | 2014 | 177 | 0.200 |
Why?
|
| Humans | 48 | 2023 | 744343 | 0.200 |
Why?
|
| Upper Extremity | 2 | 2023 | 648 | 0.190 |
Why?
|
| PPAR gamma | 1 | 2023 | 493 | 0.190 |
Why?
|
| Arm | 1 | 2023 | 589 | 0.180 |
Why?
|
| Female | 29 | 2023 | 380194 | 0.170 |
Why?
|
| Registries | 1 | 2015 | 8089 | 0.170 |
Why?
|
| Quality of Life | 2 | 2022 | 12804 | 0.170 |
Why?
|
| Radiotherapy, Adjuvant | 2 | 2015 | 1770 | 0.170 |
Why?
|
| Virilism | 1 | 2018 | 31 | 0.170 |
Why?
|
| Sirolimus | 2 | 2016 | 1564 | 0.170 |
Why?
|
| Surgical Flaps | 4 | 2020 | 1640 | 0.160 |
Why?
|
| Cells, Cultured | 5 | 2016 | 19229 | 0.160 |
Why?
|
| Genitalia, Female | 1 | 2018 | 146 | 0.150 |
Why?
|
| MAP Kinase Kinase Kinases | 1 | 2019 | 261 | 0.150 |
Why?
|
| Adipose Tissue | 4 | 2022 | 3279 | 0.150 |
Why?
|
| Bone Morphogenetic Protein Receptors, Type I | 1 | 2017 | 96 | 0.150 |
Why?
|
| Frostbite | 1 | 2017 | 24 | 0.150 |
Why?
|
| Arthroplasty | 2 | 2016 | 305 | 0.150 |
Why?
|
| Reoperation | 3 | 2017 | 4201 | 0.140 |
Why?
|
| Insulin-Like Growth Factor I | 2 | 2023 | 2015 | 0.140 |
Why?
|
| Smad5 Protein | 1 | 2016 | 27 | 0.140 |
Why?
|
| Aggrecans | 1 | 2016 | 90 | 0.140 |
Why?
|
| Adult | 16 | 2017 | 214055 | 0.140 |
Why?
|
| Mustard Compounds | 1 | 2015 | 4 | 0.140 |
Why?
|
| Smad1 Protein | 1 | 2016 | 81 | 0.140 |
Why?
|
| Phenylpropionates | 1 | 2015 | 30 | 0.140 |
Why?
|
| Receptor, TIE-2 | 1 | 2016 | 178 | 0.140 |
Why?
|
| Apatites | 1 | 2015 | 19 | 0.140 |
Why?
|
| Nerve Compression Syndromes | 1 | 2017 | 160 | 0.140 |
Why?
|
| Michigan | 1 | 2016 | 350 | 0.140 |
Why?
|
| Male | 25 | 2023 | 350118 | 0.130 |
Why?
|
| Core Binding Factor Alpha 1 Subunit | 1 | 2016 | 164 | 0.130 |
Why?
|
| Osteocalcin | 1 | 2016 | 273 | 0.130 |
Why?
|
| Sex Reassignment Surgery | 1 | 2018 | 130 | 0.130 |
Why?
|
| Mediastinitis | 1 | 2015 | 48 | 0.130 |
Why?
|
| Aromatase Inhibitors | 1 | 2019 | 491 | 0.130 |
Why?
|
| Receptors, Retinoic Acid | 1 | 2016 | 232 | 0.130 |
Why?
|
| Hair Follicle | 1 | 2017 | 209 | 0.130 |
Why?
|
| Hip | 1 | 2016 | 257 | 0.130 |
Why?
|
| Joints | 1 | 2016 | 326 | 0.130 |
Why?
|
| Mice, Obese | 1 | 2015 | 424 | 0.120 |
Why?
|
| Contracture | 1 | 2017 | 223 | 0.120 |
Why?
|
| Internal Fixators | 1 | 2015 | 188 | 0.120 |
Why?
|
| Protein-Lysine 6-Oxidase | 1 | 2014 | 60 | 0.120 |
Why?
|
| Sternotomy | 1 | 2015 | 121 | 0.120 |
Why?
|
| Middle Aged | 16 | 2017 | 213383 | 0.120 |
Why?
|
| Tissue Transplantation | 1 | 2015 | 130 | 0.120 |
Why?
|
| Gene Knockout Techniques | 1 | 2017 | 809 | 0.120 |
Why?
|
| Adaptive Immunity | 2 | 2016 | 713 | 0.120 |
Why?
|
| Rectus Abdominis | 1 | 2014 | 97 | 0.120 |
Why?
|
| Body Surface Area | 1 | 2014 | 198 | 0.120 |
Why?
|
| Protein Kinase Inhibitors | 3 | 2019 | 5535 | 0.120 |
Why?
|
| Calciphylaxis | 1 | 2015 | 124 | 0.120 |
Why?
|
| Luminescent Measurements | 1 | 2015 | 405 | 0.110 |
Why?
|
| Luminescent Proteins | 1 | 2016 | 853 | 0.110 |
Why?
|
| Aged | 12 | 2017 | 163280 | 0.110 |
Why?
|
| Pericytes | 1 | 2016 | 292 | 0.110 |
Why?
|
| Elbow Joint | 1 | 2017 | 357 | 0.110 |
Why?
|
| Kaplan-Meier Estimate | 2 | 2014 | 6538 | 0.110 |
Why?
|
| Abdominal Wall | 1 | 2014 | 157 | 0.110 |
Why?
|
| NFATC Transcription Factors | 1 | 2015 | 381 | 0.110 |
Why?
|
| Mice, Knockout | 3 | 2017 | 14557 | 0.110 |
Why?
|
| Recurrence | 2 | 2016 | 8340 | 0.110 |
Why?
|
| Bone Density | 2 | 2016 | 3468 | 0.110 |
Why?
|
| Life Expectancy | 1 | 2019 | 1184 | 0.110 |
Why?
|
| Blast Injuries | 1 | 2016 | 302 | 0.110 |
Why?
|
| Cell Proliferation | 3 | 2019 | 10481 | 0.110 |
Why?
|
| Debridement | 2 | 2017 | 492 | 0.110 |
Why?
|
| Retrospective Studies | 11 | 2017 | 77449 | 0.110 |
Why?
|
| Median Nerve | 1 | 2012 | 129 | 0.110 |
Why?
|
| Muscular Atrophy | 1 | 2015 | 349 | 0.110 |
Why?
|
| Abdominal Fat | 1 | 2014 | 223 | 0.100 |
Why?
|
| Bone Diseases, Metabolic | 1 | 2016 | 417 | 0.100 |
Why?
|
| Tendon Injuries | 1 | 2015 | 313 | 0.100 |
Why?
|
| Apyrase | 1 | 2014 | 364 | 0.100 |
Why?
|
| Cadherins | 1 | 2016 | 907 | 0.100 |
Why?
|
| Peripheral Nervous System Diseases | 1 | 2017 | 685 | 0.100 |
Why?
|
| Immunoenzyme Techniques | 1 | 2015 | 1799 | 0.100 |
Why?
|
| Diabetes Mellitus, Type 2 | 1 | 2015 | 11725 | 0.100 |
Why?
|
| Young Adult | 6 | 2017 | 56430 | 0.100 |
Why?
|
| Rats | 2 | 2019 | 24260 | 0.100 |
Why?
|
| Antineoplastic Agents, Hormonal | 1 | 2019 | 1524 | 0.100 |
Why?
|
| Stromal Cells | 1 | 2016 | 1355 | 0.090 |
Why?
|
| Animals, Newborn | 1 | 2016 | 2726 | 0.090 |
Why?
|
| Inflammation | 3 | 2019 | 10638 | 0.090 |
Why?
|
| Range of Motion, Articular | 1 | 2017 | 1578 | 0.090 |
Why?
|
| Monocytes | 1 | 2020 | 2596 | 0.090 |
Why?
|
| Methylene Blue | 1 | 2010 | 155 | 0.090 |
Why?
|
| Radiotherapy | 1 | 2017 | 1533 | 0.090 |
Why?
|
| Extracellular Matrix Proteins | 1 | 2014 | 849 | 0.090 |
Why?
|
| Ligands | 1 | 2017 | 3282 | 0.090 |
Why?
|
| Gene Regulatory Networks | 2 | 2015 | 1708 | 0.090 |
Why?
|
| Skin | 3 | 2019 | 4364 | 0.090 |
Why?
|
| Follow-Up Studies | 3 | 2016 | 39050 | 0.090 |
Why?
|
| Prognosis | 3 | 2015 | 29063 | 0.080 |
Why?
|
| Choice Behavior | 1 | 2015 | 803 | 0.080 |
Why?
|
| Piperazines | 1 | 2019 | 2488 | 0.080 |
Why?
|
| Postoperative Complications | 4 | 2015 | 15295 | 0.080 |
Why?
|
| Neoplasm Metastasis | 1 | 2019 | 4851 | 0.080 |
Why?
|
| Mastectomy, Segmental | 1 | 2014 | 956 | 0.080 |
Why?
|
| Rats, Sprague-Dawley | 2 | 2016 | 8301 | 0.080 |
Why?
|
| Models, Animal | 1 | 2015 | 2171 | 0.080 |
Why?
|
| Chimera | 1 | 2009 | 485 | 0.080 |
Why?
|
| Adenosine Triphosphate | 1 | 2014 | 2025 | 0.080 |
Why?
|
| Negative-Pressure Wound Therapy | 1 | 2010 | 150 | 0.080 |
Why?
|
| Coloring Agents | 1 | 2010 | 566 | 0.080 |
Why?
|
| Tumor Burden | 1 | 2014 | 1915 | 0.080 |
Why?
|
| Phantoms, Imaging | 1 | 2016 | 2480 | 0.080 |
Why?
|
| Decompression, Surgical | 1 | 2012 | 594 | 0.080 |
Why?
|
| Pyridines | 1 | 2019 | 2825 | 0.080 |
Why?
|
| Anti-Inflammatory Agents | 1 | 2017 | 1790 | 0.080 |
Why?
|
| Lymph Nodes | 2 | 2020 | 3474 | 0.080 |
Why?
|
| Propensity Score | 1 | 2014 | 1781 | 0.070 |
Why?
|
| Fractures, Bone | 1 | 2019 | 1947 | 0.070 |
Why?
|
| Up-Regulation | 1 | 2015 | 4217 | 0.070 |
Why?
|
| Acute Disease | 1 | 2017 | 7149 | 0.070 |
Why?
|
| Macrophages | 2 | 2020 | 5655 | 0.070 |
Why?
|
| Fibroblasts | 1 | 2016 | 4161 | 0.070 |
Why?
|
| Lymphatic Metastasis | 1 | 2014 | 2924 | 0.070 |
Why?
|
| Time Factors | 3 | 2017 | 40075 | 0.070 |
Why?
|
| Magnetic Resonance Imaging | 1 | 2012 | 35421 | 0.070 |
Why?
|
| Suture Techniques | 1 | 2010 | 798 | 0.060 |
Why?
|
| Sensitivity and Specificity | 3 | 2015 | 14722 | 0.060 |
Why?
|
| Adolescent | 4 | 2017 | 85781 | 0.060 |
Why?
|
| Body Composition | 1 | 2014 | 2401 | 0.060 |
Why?
|
| Surgical Wound Infection | 1 | 2014 | 1540 | 0.060 |
Why?
|
| Drainage | 1 | 2010 | 1142 | 0.060 |
Why?
|
| Cytokines | 2 | 2020 | 7322 | 0.060 |
Why?
|
| RNA | 1 | 2014 | 2749 | 0.060 |
Why?
|
| Fascia | 2 | 2014 | 135 | 0.060 |
Why?
|
| Gene Expression | 1 | 2016 | 7799 | 0.060 |
Why?
|
| Survival Rate | 2 | 2015 | 12788 | 0.060 |
Why?
|
| Intercostal Nerves | 1 | 2022 | 26 | 0.050 |
Why?
|
| Calcium | 1 | 2015 | 5756 | 0.050 |
Why?
|
| Porosity | 1 | 2023 | 362 | 0.050 |
Why?
|
| Tomography, X-Ray Computed | 5 | 2016 | 20129 | 0.050 |
Why?
|
| Patient Discharge | 1 | 2015 | 3313 | 0.050 |
Why?
|
| Preoperative Period | 2 | 2014 | 549 | 0.050 |
Why?
|
| Combined Modality Therapy | 1 | 2014 | 8642 | 0.050 |
Why?
|
| Aged, 80 and over | 3 | 2015 | 57776 | 0.050 |
Why?
|
| Vascular Endothelial Growth Factors | 1 | 2023 | 772 | 0.050 |
Why?
|
| Risk Factors | 4 | 2023 | 72290 | 0.050 |
Why?
|
| Lymphatic System | 1 | 2022 | 253 | 0.050 |
Why?
|
| Aging | 2 | 2023 | 8664 | 0.050 |
Why?
|
| Subcutaneous Fat | 2 | 2014 | 391 | 0.050 |
Why?
|
| Denervation | 1 | 2022 | 278 | 0.050 |
Why?
|
| Random Allocation | 2 | 2015 | 2429 | 0.050 |
Why?
|
| RNA, Messenger | 1 | 2015 | 13033 | 0.050 |
Why?
|
| Head and Neck Neoplasms | 1 | 2014 | 2734 | 0.050 |
Why?
|
| Infant, Newborn | 2 | 2017 | 25625 | 0.050 |
Why?
|
| Multivariate Analysis | 1 | 2014 | 12245 | 0.050 |
Why?
|
| Biopsy, Needle | 2 | 2015 | 1641 | 0.040 |
Why?
|
| Adipogenesis | 1 | 2022 | 359 | 0.040 |
Why?
|
| Hemodynamics | 1 | 2010 | 4199 | 0.040 |
Why?
|
| Neoplasm Staging | 1 | 2014 | 11031 | 0.040 |
Why?
|
| Proportional Hazards Models | 1 | 2014 | 12354 | 0.040 |
Why?
|
| Models, Biological | 1 | 2015 | 9583 | 0.040 |
Why?
|
| Gene Expression Regulation | 4 | 2020 | 12072 | 0.040 |
Why?
|
| Phenotype | 1 | 2016 | 16365 | 0.040 |
Why?
|
| Image Processing, Computer-Assisted | 1 | 2016 | 8949 | 0.040 |
Why?
|
| Physical Therapy Modalities | 1 | 2023 | 550 | 0.040 |
Why?
|
| DNA Nucleotidyltransferases | 1 | 2019 | 193 | 0.040 |
Why?
|
| Founder Effect | 1 | 2019 | 189 | 0.040 |
Why?
|
| Infant | 2 | 2017 | 35136 | 0.040 |
Why?
|
| Education, Medical | 1 | 2010 | 1721 | 0.040 |
Why?
|
| Child, Preschool | 2 | 2017 | 41006 | 0.040 |
Why?
|
| Rewarming | 1 | 2017 | 61 | 0.040 |
Why?
|
| Transcription Factors | 1 | 2016 | 12208 | 0.040 |
Why?
|
| Algorithms | 1 | 2017 | 13881 | 0.040 |
Why?
|
| United States | 2 | 2015 | 69872 | 0.040 |
Why?
|
| Tissue Scaffolds | 1 | 2023 | 956 | 0.030 |
Why?
|
| Transforming Growth Factor beta1 | 1 | 2020 | 644 | 0.030 |
Why?
|
| Body Weights and Measures | 1 | 2016 | 211 | 0.030 |
Why?
|
| Genetic Predisposition to Disease | 1 | 2017 | 17446 | 0.030 |
Why?
|
| Stilbenes | 1 | 2016 | 156 | 0.030 |
Why?
|
| Sampling Studies | 1 | 2017 | 623 | 0.030 |
Why?
|
| Treatment Outcome | 4 | 2017 | 63114 | 0.030 |
Why?
|
| Smad Proteins, Receptor-Regulated | 1 | 2014 | 9 | 0.030 |
Why?
|
| Foot Injuries | 1 | 2017 | 148 | 0.030 |
Why?
|
| Obesity | 2 | 2014 | 12745 | 0.030 |
Why?
|
| Transplantation, Isogeneic | 1 | 2015 | 257 | 0.030 |
Why?
|
| Cardiac Surgical Procedures | 1 | 2010 | 3537 | 0.030 |
Why?
|
| Child | 3 | 2017 | 77709 | 0.030 |
Why?
|
| Skull | 1 | 2019 | 813 | 0.030 |
Why?
|
| Phagocytosis | 1 | 2020 | 1539 | 0.030 |
Why?
|
| Risk Assessment | 4 | 2017 | 23338 | 0.030 |
Why?
|
| Hand Injuries | 1 | 2017 | 242 | 0.030 |
Why?
|
| Blood Cells | 1 | 2016 | 309 | 0.030 |
Why?
|
| Chimerism | 1 | 2014 | 158 | 0.030 |
Why?
|
| Injury Severity Score | 1 | 2017 | 1014 | 0.030 |
Why?
|
| Morphogenesis | 1 | 2017 | 752 | 0.030 |
Why?
|
| Hydrolysis | 1 | 2014 | 682 | 0.030 |
Why?
|
| Multiple Trauma | 1 | 2015 | 367 | 0.030 |
Why?
|
| Motivation | 1 | 2022 | 1971 | 0.030 |
Why?
|
| Gender Identity | 1 | 2018 | 688 | 0.030 |
Why?
|
| Tissue Engineering | 1 | 2023 | 1880 | 0.030 |
Why?
|
| Lower Extremity | 1 | 2020 | 1158 | 0.030 |
Why?
|
| Mice, Inbred Strains | 1 | 2015 | 1827 | 0.030 |
Why?
|
| Pain Measurement | 1 | 2022 | 3420 | 0.030 |
Why?
|
| Bone Development | 1 | 2015 | 483 | 0.030 |
Why?
|
| Pain, Postoperative | 1 | 2022 | 1643 | 0.030 |
Why?
|
| Immunohistochemistry | 2 | 2015 | 11366 | 0.030 |
Why?
|
| Surgical Mesh | 1 | 2014 | 276 | 0.020 |
Why?
|
| Staining and Labeling | 1 | 2015 | 1100 | 0.020 |
Why?
|
| Counseling | 1 | 2018 | 1523 | 0.020 |
Why?
|
| Mutation | 1 | 2015 | 29786 | 0.020 |
Why?
|
| International Classification of Diseases | 1 | 2015 | 867 | 0.020 |
Why?
|
| Logistic Models | 2 | 2014 | 13408 | 0.020 |
Why?
|
| Intra-Abdominal Fat | 1 | 2014 | 591 | 0.020 |
Why?
|
| Antigen Presentation | 1 | 2014 | 1284 | 0.020 |
Why?
|
| Administration, Topical | 1 | 2010 | 690 | 0.020 |
Why?
|
| Predictive Value of Tests | 2 | 2015 | 15076 | 0.020 |
Why?
|
| Reference Values | 1 | 2015 | 4982 | 0.020 |
Why?
|
| Bone Density Conservation Agents | 1 | 2015 | 773 | 0.020 |
Why?
|
| Iliac Artery | 1 | 2009 | 364 | 0.020 |
Why?
|
| Radial Artery | 1 | 2009 | 194 | 0.020 |
Why?
|
| Peptides | 1 | 2020 | 4409 | 0.020 |
Why?
|
| Blotting, Western | 1 | 2015 | 5179 | 0.020 |
Why?
|
| Spine | 1 | 2014 | 1144 | 0.020 |
Why?
|
| ROC Curve | 1 | 2014 | 3527 | 0.020 |
Why?
|
| Analysis of Variance | 1 | 2015 | 6365 | 0.020 |
Why?
|
| Flow Cytometry | 1 | 2016 | 5974 | 0.020 |
Why?
|
| Pyrazoles | 1 | 2016 | 1972 | 0.020 |
Why?
|
| Polymerase Chain Reaction | 1 | 2015 | 6171 | 0.020 |
Why?
|
| Anti-Inflammatory Agents, Non-Steroidal | 1 | 2015 | 2282 | 0.020 |
Why?
|
| Femoral Artery | 1 | 2009 | 845 | 0.020 |
Why?
|
| Graft Survival | 1 | 2014 | 3737 | 0.010 |
Why?
|
| Phosphorylation | 1 | 2014 | 8436 | 0.010 |
Why?
|
| Risk | 1 | 2014 | 9687 | 0.010 |
Why?
|
| Imaging, Three-Dimensional | 1 | 2015 | 4042 | 0.010 |
Why?
|
| Pain | 1 | 2017 | 4986 | 0.010 |
Why?
|
| Sex Factors | 1 | 2015 | 10397 | 0.010 |
Why?
|
| Analgesics, Opioid | 1 | 2017 | 3674 | 0.010 |
Why?
|
| Comorbidity | 1 | 2014 | 10388 | 0.010 |
Why?
|
| Longitudinal Studies | 1 | 2015 | 13989 | 0.010 |
Why?
|
| Research Design | 1 | 2015 | 5987 | 0.010 |
Why?
|
| Reproducibility of Results | 1 | 2015 | 19905 | 0.010 |
Why?
|
| Case-Control Studies | 1 | 2014 | 21746 | 0.010 |
Why?
|
| Incidence | 1 | 2014 | 20947 | 0.010 |
Why?
|
| Prospective Studies | 1 | 2016 | 53288 | 0.010 |
Why?
|